Integra Lifesciences Holdings (IART) Return on Capital Employed (2010 - 2026)
Integra Lifesciences Holdings (IART) posted Return on Capital Employed of 2.02% for Q2 2026, up 114.07% sequentially from 14.38% in Q1 2026, and up 1911.0% YoY from 0.1% in Q2 2025.
Integra Lifesciences Holdings (IART) Return on Capital Employed (2010 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Return on Capital Employed for 17 years, with the latest figure at 2.02% in Q2 2026.
- Quarterly Return on Capital Employed rose 1911.0% year-over-year to 2.02% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2.02% (up 1911.0% YoY) and the FY2025 annual result came in at 14.67%, down 1562.0% from the prior year.
- Return on Capital Employed grew to 2.02% in Q2 2026 per IART's latest filing, from 14.38% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 6.77% in Q4 2022 and troughed at 17.09% in Q2 2025.
- A 5-year average of 0.46% and a median of 2.1% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed sank 1878 bps in 2025, then surged 1911 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 6.77% in 2022, then slumped by 52 bps to 3.23% in 2023, then slumped by 72 bps to 0.91% in 2024, then sank by 1815 bps to 15.57% in 2025, then jumped by 113 bps to 2.02% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 2.02%, 14.38%, and 15.57% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 2.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02% |
| Mar 31, 2026 | -14.38% |
| Dec 31, 2025 | -15.57% |
| Sep 30, 2025 | -14.60% |
| Jun 30, 2025 | -17.09% |
| Mar 31, 2025 | 0.29% |
| Dec 31, 2024 | 0.91% |
| Sep 30, 2024 | 0.91% |
| Jun 30, 2024 | 1.70% |
| Mar 31, 2024 | 2.18% |
| Dec 31, 2023 | 3.23% |
| Sep 30, 2023 | 4.21% |
| Jun 30, 2023 | 5.37% |
| Mar 31, 2023 | 6.48% |
| Dec 31, 2022 | 6.77% |
| Sep 30, 2022 | 6.60% |
| Jun 30, 2022 | 6.46% |
| Mar 31, 2022 | 6.23% |
| Dec 31, 2021 | 5.74% |
| Sep 30, 2021 | 5.62% |